Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


29.04.2019

1 Ann Surg Oncol
2 Anticancer Res
1 Br J Cancer
1 Cancer
1 Cancer Lett
1 Clin Cancer Res
2 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
1 Gut
3 Int J Cancer
2 Int J Colorectal Dis
1 J Surg Oncol
2 Lancet Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. KOTHA NV, Baumgartner JM, Veerapong J, Cloyd JM, et al
    Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07373.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. PINELLI A, Ferrario P, Trivulzio S
    Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
    Anticancer Res. 2019;39:1807-1812.
    PubMed     Text format     Abstract available

  3. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
    The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Anticancer Res. 2019;39:1719-1728.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. BANDO H, Kagawa Y, Kato T, Akagi K, et al
    A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
    Br J Cancer. 2019 Apr 24. pii: 10.1038/s41416-019-0457.
    PubMed     Text format     Abstract available


    Cancer

  5. GEORGE TJ, Franke AJ, Chakravarthy AB, Das P, et al
    National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
    Cancer. 2019 Apr 24. doi: 10.1002/cncr.32150.
    PubMed     Text format     Abstract available


    Cancer Lett

  6. HUANG Q, Chen Z, Cheng P, Huang Y, et al
    LYRM2 directly Regulates Complex I Activity to Support Tumor Growth in Colorectal Cancer by Oxidative Phosphorylation.
    Cancer Lett. 2019 Apr 17. pii: S0304-3835(19)30252.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. PISKOL R, Huw LY, Sergin I, Klijn C, et al
    A Clinical Applicable Gene Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
    Clin Cancer Res. 2019 Apr 19. pii: 1078-0432.CCR-18-3032.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  8. BARNELL GM, Ajayi O, Tolan-Riley A, Dixon MR, et al
    A Team-Based Approach to Anal Cancer Screening and Prevention.
    Dis Colon Rectum. 2019;62:e13.
    PubMed     Text format    

  9. KALADY MF
    Expert Commentary on the Diagnosis and Management of Lynch Syndrome.
    Dis Colon Rectum. 2019;62:406-407.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  10. WANG SL, Wang Q, Yao J, Zhao SB, et al
    Effect of WeChat and short message service on bowel preparation: an endoscopist-blinded, randomized controlled trial.
    Eur J Gastroenterol Hepatol. 2019;31:170-177.
    PubMed     Text format     Abstract available


    Gut

  11. VAUGHAN-SHAW PG, Zgaga L, Ooi LY, Theodoratou E, et al
    Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Gut. 2019 Apr 25. pii: gutjnl-2018-317922. doi: 10.1136/gutjnl-2018-317922.
    PubMed     Text format     Abstract available


    Int J Cancer

  12. KHAN N, Jajeh F, Eberhardt EL, Miller DD, et al
    Fisetin and 5-Fluorouracil: Effective Combination for PIK3CA-Mutant Colorectal Cancer.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32367.
    PubMed     Text format     Abstract available

  13. DE KORT S, Simons CCJM, van den Brandt PA, Janssen-Heijnen MLG, et al
    Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32365.
    PubMed     Text format     Abstract available

  14. BARRY EL, Lund JL, Westreich D, Mott LA, et al
    Body mass index, calcium supplementation and risk of colorectal adenomas.
    Int J Cancer. 2019;144:448-458.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  15. FAN Y, Xiang S, Dai Z, Zou C, et al
    Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Int J Colorectal Dis. 2019 Apr 23. pii: 10.1007/s00384-019-03299.
    PubMed     Text format     Abstract available

  16. SHEN F, Cui J, Hong X, Yu F, et al
    Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2.
    Int J Colorectal Dis. 2019 Apr 23. pii: 10.1007/s00384-019-03298.
    PubMed     Text format     Abstract available


    J Surg Oncol

  17. LINO-SILVA LS, Anchondo-Nunez P, Chit-Huerta A, Aguilar-Romero E, et al
    Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
    J Surg Oncol. 2019 Apr 24. doi: 10.1002/jso.25482.
    PubMed     Text format     Abstract available


    Lancet Oncol

  18. ENG C, Kim TW, Bendell J, Argiles G, et al
    Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
    Lancet Oncol. 2019 Apr 16. pii: S1470-2045(19)30027.
    PubMed     Text format     Abstract available

  19. SCLAFANI F
    MEK and PD-L1 inhibition in colorectal cancer: a burning blaze turning into a flash in the pan.
    Lancet Oncol. 2019 Apr 16. pii: S1470-2045(19)30076.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: